(lp0
S'BG Medicine: Nearing The Finish Line Seeking Alpha - Dec 3, 2015 When BG Medicine  went public nearly a half decade ago, it did so with much fanfare and hope for the future of its FDA approved Galectin-3 test to predict heart failure in individuals already diagnosed with the disease.'
p1
aS'Why BG Medicine  Is Up Today TheStreet.com - Jan 28, 2014 &quot;We rate BG MEDICINE INC  a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we&nbsp;...'
p2
aS"Short interest Of BG Medicine, Inc.  At 630048 Markets Daily - Mar 17, 2017 BG Medicine, Inc. was given a 100 for the session as on 2017-03-09. The systematic procedure of listing and placing opinions in the form of articles, specifically to recommend the author's standpoint, whether impartial, undesirable or favorable ..."
p3
aS'Brokers Add To Their Ratings On BG Medicine, Inc.  NewsDen - 19 hours ago A number of investment brokers have recently updated their price targets on shares of BG Medicine, Inc. . Most recent broker ratings.'
p4
aS'BG Medicine  Seeks Additional Indication from FDA for BGM Galectin-3 Test StreetInsider.com - Mar 31, 2015 BG Medicine, Inc. , the developer of the BGM Galectin-3 Test, today reported that it has filed a 510 Premarket Notification with U.S.'
p5
aS'First Automated Test for Galectin-3 Now Available in US GlobeNewswire  - Jul 6, 2015 WALTHAM, Mass., July 6, 2015  -- BG Medicine, Inc. , the developer of the BGM Galectin-3 Test, today announced that the ARCHITECT Galectin-3 assay is now available.'
p6
aS'BG Medicine  Stock Declines | Earnings Report Released CNA Finance  - Mar 31, 2015 BGMD Stock News BG Medicine, Inc.  BG Medicine stocks fell in a big way in morning trading today after the company released its earnings report before the bell.'
p7
aS"In Volatile Markets Do Analysts Think You Should Buy BG Medicine, Inc. ? The De Soto Edge - Mar 15, 2017 11/13/2014 - BG Medicine, Inc. was downgraded to  by analysts at Ladenburg Thalmann. The share price of BG Medicine, Inc.  was up +9.86% during the last trading session, with a day high of 0.08. 500 shares were traded on BG Medicine, Inc.'s&nbsp;..."
p8
aS'BG Medicine  Reports FDA Clearance of Automated Galectin-3 Testing  StreetInsider.com  - Dec 30, 2014 BG Medicine, Inc.   is the developer of the BGM Galectin-3 Test, which is the FDA-cleared manual microtiter plate version of the galectin-3 test, and the licensor of this first automated galectin-3 assay, which is used with ...'
p9
aS'Basic Consolidated EPS Of BG Medicine, Inc.  At $-0.5519 Equities Focus - Mar 16, 2017 From the parent firm, BG Medicine, Inc.  received diluted EPS of $-0.5519 for the annual period settled 2015-12-31.'
p10
a.